ML 315
Modify Date: 2025-08-25 16:15:35
ML 315 structure
|
Common Name | ML 315 | ||
|---|---|---|---|---|
| CAS Number | 1440251-53-5 | Molecular Weight | 374.22 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 558.0±50.0 °C at 760 mmHg | |
| Molecular Formula | C18H13Cl2N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 291.2±30.1 °C | |
Use of ML 315ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research[1]. |
| Name | ML 315 hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 558.0±50.0 °C at 760 mmHg |
| Molecular Formula | C18H13Cl2N3O2 |
| Molecular Weight | 374.22 |
| Flash Point | 291.2±30.1 °C |
| Exact Mass | 373.038483 |
| LogP | 5.10 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.682 |
| MFCD30833328 |
| 5-(1,3-Benzodioxol-5-yl)-N-(3,5-dichlorobenzyl)-4-pyrimidinamine |
| 4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]- |
| ML315 |
| 5-(1,3-Benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-4-pyrimidinamine hydrochloride |